---
title: Treatments for major depression
videoId: Xu1FMCxoEFc
---

From: [[hubermanlab]] <br/> 
Major depression is a pervasive mental disorder affecting approximately 5% of the population, and it is a significant contributor to disability worldwide (<a class="yt-timestamp" data-t="00:14:41">[00:14:41]</a>). Understanding and effectively treating major depression is crucial due to its complex interplay of psychological and biological factors. This article discusses various treatments for major depression, ranging from behavioral to pharmacological interventions.

## Overview of Major Depression

Major depression is characterized by persistent sadness, anhedonia (lack of pleasure in previously enjoyed activities), guilt, and vegetative symptoms such as changes in sleep and appetite (<a class="yt-timestamp" data-t="00:16:15">[00:16:15]</a>).

## Biological Basis and Treatment Approaches

Various neurochemical systems play roles in major depression, including norepinephrine, dopamine, and serotonin pathways. This understanding guides treatments that aim to adjust these neurotransmitters at different levels [[role_of_dopamine_and_serotonin_in_depression | role of dopamine and serotonin in depression]] (<a class="yt-timestamp" data-t="00:38:02">[00:38:02]</a>).

### Pharmacological Treatments

1. **SSRIs (Selective Serotonin Reuptake Inhibitors):** These drugs enhance serotonin efficacy in the brain. They're effective in alleviating symptoms in approximately two-thirds of individuals, though they carry potential side effects such as altered libido and appetite [[role_of_diet_and_supplements_in_managing_adhd | role of diet and supplements in managing ADHD]] (<a class="yt-timestamp" data-t="00:32:02">[00:32:02]</a>).

2. **MAO Inhibitors and Tricyclic Antidepressants:** Initially discovered for their mood-stabilizing effects, these increase norepinephrine but have extensive side effects making them less favorable [[experimental_treatments_for_depression | experimental treatments for depression]] (<a class="yt-timestamp" data-t="00:28:23">[00:28:23]</a>).

3. **Ketamine and PCP:** Emerging as promising treatments, these dissociative anesthetics offer fast relief by affecting the NMDA receptor involved in neuronal plasticity. They help disconnect depressive circuitry, potentially leading to symptom alleviation [[ketamine_and_neuroplasticity | ketamine and neuroplasticity]] (<a class="yt-timestamp" data-t="01:24:22">[01:24:22]</a>).

4. **Psychedelics like Psilocybin:** These are being studied for their potential to rewire brain circuitry and offer long-term relief from depressive symptoms with controlled dosages administered in clinical settings [[therapeutic_benefits_of_psilocybin_for_mental_health | therapeutic benefits of psilocybin for mental health]] (<a class="yt-timestamp" data-t="01:37:02">[01:37:02]</a>).

### Behavioral and Lifestyle Interventions

1. **Exercise:** Regular aerobic and resistance exercise can stimulate dopamine and serotonin pathways and is shown to be protective against depression [[impact_of_exercise_on_brain_and_body_health | impact of exercise on brain and body health]] (<a class="yt-timestamp" data-t="00:54:22">[00:54:22]</a>).

2. **Dietary Supplements:**
   - **EPA (Eicosapentaenoic Acid):** Omega-3 fatty acids, particularly EPA, taken in sufficient quantities (~1000 mg daily) can match some pharmacological interventions in efficacy for combating depression [[the_role_of_omega3_fatty_acids | the role of Omega-3 fatty acids]] (<a class="yt-timestamp" data-t="01:00:10">[01:00:10]</a>).
   - **Creatine:** Known for enhancing physical performance, creatine supplementation may also support mood by modulating brain chemistry [[nutrition_and_mental_health | nutrition and mental health]] (<a class="yt-timestamp" data-t="01:12:07">[01:12:07]</a>).

3. **Ketogenic Diet:** This diet's role in epilepsy treatment through GABA modulation hints at its potential for managing stubborn depressive symptoms by altering neurotransmitter dynamics [[ketogenic_diet_for_psychiatric_disorders | ketogenic diet for psychiatric disorders]] (<a class="yt-timestamp" data-t="01:50:43">[01:50:43]</a>).

### Novel Interventions

Neuroplasticity plays a central role in treating depression. Innovative therapies focusing on NMDA receptors, whether through pharmacological agents or psychedelic substances, aim to restructure brain circuits responsible for depressive symptoms [[neurobiology_and_psychedelics_and_their_effects_on_brain_state_and_empathy | neurobiology of psychedelics and their effects on brain state and empathy]] (<a class="yt-timestamp" data-t="01:33:02">[01:33:02]</a>).

> [!info] Note
> People considering changes to their treatment plan should always consult with a healthcare provider to ensure the safety and suitability of any intervention, especially when contemplating interventional treatments or discontinuing prescribed medications [[tools_for_improving_mood_and_mental_health | tools for improving mood and mental health]] (<a class="yt-timestamp" data-t="01:44:01">[01:44:01]</a>).

## Conclusion

The multifaceted approach to treating major depression includes traditional pharmacotherapy, emerging experimental treatments, and lifestyle modifications. Rigorous scientific study continues to explore these pathways, providing hope for more effective, tailored treatments for individuals struggling with this disorder [[biological_basis_of_depression_and_mood_disorders | biological basis of depression and mood disorders]].